CAR-T Meeting 2023 | CAR-T cell therapy for T-cell malignancies: challenges to address and future outlooks
Maksim Mamonkin
• 10 Feb 2023
In this video, Maksim Mamonkin, PhD, Baylor College of Medicine, Houston, TX, discusses the challenges with developing CAR-T cells for the treatment of T-cell malignancies, emphasizing the need to avoid fratricide and T-cell aplasia, and further discusses approaches being explored to prevent these. and This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research funding: Fate
Royalties and License fees: Fate, Allogene, March Bio
Equity: March Bio
Consulting: March Bio
